Kalin Katherine Bach 4
4 · SELLAS Life Sciences Group, Inc. · Filed Nov 21, 2025
Insider Transaction Report
Form 4
Kalin Katherine Bach
Director
Transactions
- Purchase
Common Stock
2025-11-19$1.59/sh+63,400$100,806→ 104,400 total
Footnotes (1)
- [F1]The price reflects the weighted average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $1.555 to $1.625 per share. Ms. Kalin undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.